IGE+XAO: Operational profitability 2017/2018 (17 months):

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
40
IGE+XAO: Operational profitability 2017/2018 (17 months): 29.2%

Toulouse, IGE+XAO Group announces:

Annual consolidated financial statement for the 2017/2018 financial period (in IFRS format)* and pro-forma consolidated financial statements for the calendar year 2018

            Operational profitability 2017/2018 (17 months): 29.2%

Consolidated Profit & Loss In EUR 31/12/2018 audited 31/12/2018 audited 31/12/2017 not audited Evolution 31/07/2017 audited
  17 months 12 months 12 months   12 months
Revenues 44,266,861 31,886,483 30,871,415 3.3 % 29,439,230
  Operating revenues 1,199,956 827,743 874,572 -5.4 % 907,746
  Operating expenses -32,801,829 -23,437,049 -22,886,177 2.4 % -22,401,426
Operating income (loss) 12,664,988 9,277,177 8,859,811 4.7 % 7,945,550
Consolidated income before tax 12,915,967 9,463,158 9,037,944 4.7 % 8,223,769
  Income tax -3,659,926 -2,631,245 -2,456,187 7.1 % -2,314,893
Consolidated income 9,203,955 6,762,098 6,547,988 3.3 % 5,857,121
Net result - Group 9,044,891 6,606,543 6,469,090 2.1 % 5,781,563
Consolidated turnover In EUR 31/12/2018 audited 31/12/2017 not audited Evolution
  12 months 12 months  
1 st quarter From 1 January to 31 March 7,937,004 7,578,089 4.7 %
2 nd quarter From 1 April to 30 June 8,076,291 8,418,785 -4.1 %
3 rd quarter From 1 July to 30 September 7,484,294 7,209,186 3.8 %
4 th quarter From 1 October to 31 December 8,388,894 7,665,355 9.4 %
  From 1 January to 31 December 31,886,483 30,871,415 3.3 %

Following the change in the close-out date of the accounts decided by the Combined Shareholders' Meeting of 25 June 2018, the 2017/2018 financial period, closed out at 31 December 2018, has an exceptional duration of 17 months. The related consolidated turnover stands at 44,266,861 euros; operational profitability and net profitability reached 29.2% and 20.4% compared respectively to 27.9% and 19.6% as at 31 July 2017, the close-out date of the latest published financial statements.

In order to better apprehend the change in the activity, pro-forma statements have been drawn up based on the twelve months of the calendar year. Thus, over the year 2018, consolidated turnover which stands at 31,886,483 euros is up 3.3% compared to 2017, or growth of 3.7% on a like-for-like basis (excluding the impact of the application of IFRS 15** over this period). The fourth quarter was particularly dynamic with consolidated turnover reaching 8,388,894 euros compared to 7,665,355 euros one year ago, which is an increase of 9.4%.

The growth in the activity, along with good control of expenses is accompanied by a substantial change in profitability with operating income over the year 2018 reaching 9,277,177 euros, which is operational profitability of 29.7%***, and total consolidated net income of 6,762,098 euros as such bringing net profitability to 20.7%****.    With regards to Research and Development, the period was dynamic with particular efforts on its software for the design and manufacture of electrical cabinets and cables, maintenance and troubleshooting and advanced management of electrical equipment catalogues.

Backed with these results and solid fundamentals, IGE+XAO, now a Schneider Electric company, intends to pursue its action plan, having as objectives to accelerate international development, strong investment in R&D and a high level of profitability.

*     The consolidated financial statements were approved by the Board of Directors on 11 February 2019 and will be submitted for approval to the Annual Shareholders' Meeting.

**    Application of IFRS 15 does not significantly affect the Group's consolidated financial statements as at 31 December 2018

***   Operational profitability: operating income / turnover 

**** Net profitability: net income / turnover 

About the IGE+XAO Group For over 32 years, the IGE+XAO Group has been a software publisher designing, producing, selling and supporting a range of Computer Aided Design (CAD), Product Lifecycle Management (PLM) and Simulation software dedicated to Electrical Engineering. These software products have been designed to help companies in the design and maintenance of the electrical part of any type of installation. This type of CAD/PLM/Simulation is called "Electrical CAD/PLM/Simulation". Since mid-2014 with the takeover of Prosyst, IGE+XAO also offers a complete software range for electrical installation functional simulation. IGE+XAO employs 380 people around the world in 33 sites and in 22 countries, and has more than 90,800 licenses distributed around the world. IGE+XAO is a reference in its field. For more information: http://www.ige-xao.com

IGE+XAO Group contacts IGE+XAO Group, 16 boulevard Déodat de Séverac – CS 90 312 – 31 773 COLOMIERS CEDEX Phone: +33 (0)5 62 74 36 36 – Fax: +33 (0)5 62 74 36 37 Website: www.ige-xao.com Listed on Euronext Paris – Compartment B – CAC Mid & Small® Index – ISIN FR 0000030827 Analysts/Investors: Alain Di Crescenzo (Chairman of the Group) +33 (0)5 62 74 36 36 Press Contact: Rozenn Nerrand-Destouches: +33 (0) 5 62 74 36 02

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

ING's Successful Share Buyback and New €1.6 Billion Plan

Updated Category News Views 246

ING Finalizes Share Buyback and Unveils New Distribution Strategy Recently, ING announced that it has successfully completed its comprehensive share buyback program. This initiative, which commenced earlier, concluded with the repurchase of an impressive total of 101,193,469 ordinary shares at an average price of €19.77, resulting in a total expenditure of approximately...

Continue Reading
Aicuris' Pritelivir Shows Promise for Immunocompromised Patients

Updated Category News Views 203

Breakthrough Results for Pritelivir in Immunocompromised Patients Pritelivir has distinguished itself in the realm of treatment for refractory Herpes Simplex Virus (HSV) infections among immunocompromised patients. The recent Phase 3 trial reported a statistically significant superiority in lesion healing compared to standard-of-care treatments, demonstrating the...

Continue Reading
Market Insights: Bitcoin's Stability Amidst Altcoin Declines

Updated Category News Views 213

Market Dynamics: Bitcoin Stands Firm as Altcoins Dwindle In a recent turn of events, leading altcoins such as Ethereum and XRP experienced significant price drops, indicating a potential shift in the cryptocurrency market's dynamics. This selloff occurred after a period of robust growth within the broader market, shaking investor confidence. Understanding the Market...

Continue Reading
American Rebel Holdings Partners with Ace Distributing in PA

Updated Category News Views 164

American Rebel Holdings Strengthens Beer Distribution Network Ace Distributing, a prestigious beer wholesaler with a rich history, has joined the American Rebel Light Beer family. This partnership marks a significant step in American Rebel's strategy to enhance its distribution network across Pennsylvania. The Partnership Breakdown American Rebel Holdings, Inc. (NASDAQ:...

Continue Reading
Core Natural Resources Delivers Strong Q3 Performance Insights

Updated Category News Views 143

Core Natural Resources Achieves Impressive Q3 Results Core Natural Resources, Inc. (NYSE: CNR) has just reported an exciting fiscal performance for its third quarter, showcasing substantial growth in net cash generated from operating activities and increased shareholder returns. Strong Financial Milestones The company generated net cash provided by operating activities...

Continue Reading